On offer is access to an atomic resolution Solid State NMR (SSNMR) at Medicines Discovery Catapult’s facility within the University of Warwick, along with world-leading scientific support, including data analysis and interpretation. Through this Call Medicines Discovery Catapult aims to provide atomic resolution of a compound, protein structure or complex and its dynamic interactions, which are not normally amenable to resolution by other approaches.

UK-registered micro, small or medium-sized enterprises engaged in drug discovery and drug re-purposing are invited to apply by Thursday 30 November.  

This collaboration is likely to be of interest to those who:

·          Need drug-target interaction data including for large or complex drug targets

·          Want to identify dynamic and conformational changes in the target

·          Have reached the limits of their structure guided approach

·          Want to explore high-resolution polymorph, metabolite, or pro-drug structural analysis

Dr Peter Simpson, Chief Scientific Officer of Medicines Discovery Catapult says:

“We’re looking for innovative, dynamic partners with technically feasible proposals that will bring about significant new advances. This is an excellent opportunity for a UK SME to accelerate their R&D.

“At Medicines Discovery Catapult, our work is all about collaboration. We are bringing together the best minds, industry expertise and equipment to speed up the development of new medicines. We look forward to hearing from interested parties who wish to translate research into new solutions for improved patient health using Atomic Resolution SSNMR for structure determination in medicine discovery or development.” 

Anyone interested in applying can find out more and download an application form at https://md.catapult.org.uk/news/call-for-collaboration-SSNMR